ClinicalTrials.Veeva

Menu

PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC (PROMPT-HF-AUMC)

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Enrolling

Conditions

Heart Failure With Reduced Ejection Fraction

Treatments

Other: Best practice alert for the notification of patients with HFrEF and recommended evidence-based therapies

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06344910
20230416-C1_v2

Details and patient eligibility

About

This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.

Enrollment

900 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Treatment for HFrEF at the outpatient clinic cardiology.
  • Documented reduced ejection fraction of <40% based on cardiac ultrasound or cardiac magnetic resonance imaging.

Exclusion criteria

  • Opt-out for the use of routine clinical data for research purposes

Trial design

900 participants in 1 patient group

Patients with HFrEF
Treatment:
Other: Best practice alert for the notification of patients with HFrEF and recommended evidence-based therapies

Trial contacts and locations

2

Loading...

Central trial contact

A Uijl; Folkert Assselbergs, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems